<DOC>
	<DOCNO>NCT00286819</DOCNO>
	<brief_summary>This open -label randomize phase II study dose-dense Fluorouracil/Epirubicin/Cyclophosphamide ( FEC ) administer Epirubicin 75mg/m2 ( FEC75 ) Epirubicin 90mg/m2 ( FEC90 ) untreated patient early breast cancer .</brief_summary>
	<brief_title>Dose Density FU 75 FU 90 Adjuvant Therapy Early Breast Cancer</brief_title>
	<detailed_description>Arm A : FEC75 regimen give follow dos : Fluorouracil 500mg/m2 i.v . bolus infusion . Epirubicin 75mg/m2 30 minute i.v infusion Cyclophosphamide 500mg/m2 i.v bolus infusion . All three drug administer intravenously Day 1 14-day cycle . Arm B : FEC90 regimen give follow dos : Fluorouracil 500mg/m2 i.v . bolus infusion.Epirubicin 90mg/m2 30 minute i.v infusion Cyclophosphamide 500mg/m2 i.v bolus infusion . All three drug administer intravenously Day 1 14-day cycle . Pegfilgrastim fix dose 6mg single subcutaneous injection give arm Day 2 cycle . Six cycle adjuvant chemotherapy administer arm ( A + B )</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>patient histological diagnosis invasive breast cancer Patients early stage I , II , III breast cancer amendable complete surgical resection . Patients nodal status Patients ER PR negative tumor . In case axillary involvement : hormonal receptor status . perfomance Status 01 ECOG Scale patient indicate adjuvant chemotherapy No previous chemotherapy radiotherapy Patients randomize within 8 week surgery . Its recommended patient start chemotherapy within 1 month surgical treatment . active infection pregnancy/breast feed serious concomitant systemic disorder incompatible study Second primary malignancy ( expect situ carcinoma cervix adequately treat basal cell carcinoma skin ) Use investigational agent within 4 week enrollment study Cocurrent administration radiation therapy , chemotherapy , hormonal therapy immunotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>early breast cancer ,</keyword>
	<keyword>Fluorouracil</keyword>
</DOC>